Henry Schein (NASDAQ:HSIC) Upgraded to Overweight at JPMorgan Chase & Co.

by · The Cerbat Gem

JPMorgan Chase & Co. upgraded shares of Henry Schein (NASDAQ:HSIC – Free Report) from a neutral rating to an overweight rating in a research report sent to investors on Tuesday morning, MarketBeat Ratings reports. The firm currently has $82.00 target price on the stock, up from their previous target price of $71.00.

HSIC has been the topic of a number of other reports. UBS Group dropped their price target on Henry Schein from $82.00 to $75.00 and set a neutral rating on the stock in a research report on Tuesday, November 14th. StockNews.com cut Henry Schein from a buy rating to a hold rating in a research report on Monday, December 4th. Piper Sandler lowered their price objective on Henry Schein from $94.00 to $84.00 and set an overweight rating on the stock in a research report on Thursday, October 26th. TheStreet cut Henry Schein from a b- rating to a c+ rating in a research report on Thursday, November 2nd. Finally, Morgan Stanley lowered their price objective on Henry Schein from $69.00 to $65.00 and set an underweight rating on the stock in a research report on Tuesday, November 14th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of Moderate Buy and an average target price of $79.25.

Check Out Our Latest Research Report on HSIC

Henry Schein Stock Performance

Shares of HSIC opened at $74.15 on Tuesday. The company has a quick ratio of 1.09, a current ratio of 1.97 and a debt-to-equity ratio of 0.42. The business’s 50 day moving average price is $68.70 and its 200-day moving average price is $74.03. Henry Schein has a 52 week low of $60.01 and a 52 week high of $89.72. The stock has a market cap of $9.64 billion, a P/E ratio of 22.07, a P/E/G ratio of 2.72 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings results on Monday, November 13th. The company reported $1.32 EPS for the quarter, hitting analysts’ consensus estimates of $1.32. Henry Schein had a return on equity of 16.08% and a net margin of 3.51%. The firm had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.21 billion. During the same period in the previous year, the firm posted $1.15 EPS. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. Equities research analysts anticipate that Henry Schein will post 4.56 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Henry Schein

Several hedge funds and other institutional investors have recently modified their holdings of the company. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Henry Schein by 2.4% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock valued at $459,000 after buying an additional 122 shares during the period. Sequoia Financial Advisors LLC lifted its holdings in shares of Henry Schein by 2.7% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,116 shares of the company’s stock valued at $415,000 after buying an additional 133 shares during the period. Contravisory Investment Management Inc. lifted its holdings in shares of Henry Schein by 2.1% during the 2nd quarter. Contravisory Investment Management Inc. now owns 6,895 shares of the company’s stock valued at $559,000 after buying an additional 141 shares during the period. CWM LLC lifted its holdings in shares of Henry Schein by 3.1% during the 2nd quarter. CWM LLC now owns 4,847 shares of the company’s stock valued at $393,000 after buying an additional 144 shares during the period. Finally, Studio Investment Management LLC lifted its holdings in shares of Henry Schein by 3.9% during the 4th quarter. Studio Investment Management LLC now owns 4,160 shares of the company’s stock valued at $332,000 after buying an additional 155 shares during the period. 93.31% of the stock is owned by institutional investors.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles